Literature DB >> 1309301

Differentiation markers in hemangiopericytoma.

Z Nemes1.   

Abstract

Normal pericytes were found to express factor XIIIa (F-XIII) and histocompatibility antigen HLA-DR. These markers were studied in 15 hemangiopericytomas (HPC) and 16 other tumors with an HPC-like pattern. A subpopulation of tumor cells expressing F-XIII and HLA-DR antigens was a constant feature of HPC and supported their pericytic origin. Meningeal HPC did not differ in phenotype from peripheral soft tissue HPC. Most tumors with an HPC-like pattern (including synovial sarcomas, malignant schwannomas, leiomyosarcomas, and liposarcomas) were negative for F-XIII and HLA-DR. Malignant fibrous histiocytomas, however, invariably contained a subpopulation expressing these antigens. Therefore, F-XIII can be considered as a marker of fibrohistiocytic differentiation in HPC. Individual tumor cells in HPC occasionally were positive for factor VIII-related antigen (F-VIII-R-Ag), suggesting that the spectrum of differentiation in HPC may include the endothelial cell line. The differentiation characteristics of HPC support the concept that pericytes are primitive cells that may act as precursors to other mesenchymal cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309301     DOI: 10.1002/1097-0142(19920101)69:1<133::aid-cncr2820690124>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Hemangiopericytoma of the sigmoid mesentery: report of a case with immunohistochemical findings.

Authors:  T Nakagawa; Y Shinoda; Y Masuko; T Ohshima; K Shirota; Y Yoshida; K Ogawa; J Uchino
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Biphenotypic sinonasal sarcoma: an expanded immunoprofile including consistent nuclear β-catenin positivity and absence of SOX10 expression.

Authors:  Lisa M Rooper; Shih-Chiang Huang; Cristina R Antonescu; William H Westra; Justin A Bishop
Journal:  Hum Pathol       Date:  2016-04-29       Impact factor: 3.466

3.  Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.

Authors:  E Hatva; T Böhling; J Jääskeläinen; M G Persico; M Haltia; K Alitalo
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

4.  The status of MGMT protein expression is a prognostic factor for meningeal hemangiopericytoma: a clinicopathologic and immunohistochemical study of 12 cases at a single institution.

Authors:  I-Wei Chang; Jui-Wei Lin; You-Ting Wu
Journal:  J Neurooncol       Date:  2011-06-11       Impact factor: 4.130

5.  Recurrent haemoptysis in a young woman: a case of a malignant haemangiopericytoma of the lung.

Authors:  T B Rothe; W Karrer; J O Gebbers
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

6.  Treatment of aphakic malignant glaucoma using Nd:YAG laser posterior capsulotomy.

Authors:  B C Little
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

7.  Conjunctival haemangiopericytoma.

Authors:  S Sujatha; R Sampath; R E Bonshek; A B Tullo
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

8.  Immunohistochemical and genetic markers to distinguish hemangiopericytoma and meningioma.

Authors:  Penglai Zhao; Tongming Zhu; Qisheng Tang; Hongyi Liu; Jianhong Zhu; Wenbin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

9.  Haemangiopericytoma of the thyroid gland in combination with Hashimoto's disease.

Authors:  T Hansen; A Gaumann; M Ghalibafian; A Höferlin; A Heintz; C J Kirkpatrick
Journal:  Virchows Arch       Date:  2004-07-09       Impact factor: 4.064

10.  Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1.

Authors:  M M Verbeek; I Otte-Höller; P Wesseling; D J Ruiter; R M de Waal
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.